Skip to product information

Gastroenterology and Hepatology Board Review 2023 (Videos)

Gastroenterology and Hepatology Board Review 2023 (Videos)

Regular price $40.00 USD
Regular price $40.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Gastroenterology and Hepatology Board Review 2023

Gastroenterology and Hepatology Board Review 2023 (Videos)

Regular price $40.00
Regular price $40.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Gastroenterology and Hepatology Board Review 2023 (Videos)

    #Gastroenterology and #Hepatology #Board_Review 2023 (Videos)


    Gastroenterology and Hepatology Board Review is an online video CME program covering normal function, signs, symptoms, and diseases of the gastrointestinal organs — from the esophagus and stomach to the small intestine, colon, liver, pancreas, and biliary tract.
    • This continuing medical education program includes 40+ one-hour lectures delivered by recognized experts with extensive clinical experience. You’ll benefit from the decision-making expertise of these skilled educators as they discuss diagnostic procedures, medical therapy, surgical therapy, and procedural therapy. Presentations combine scientific evidence and clinical judgment, culminating with recommendations for the most appropriate care and improved patient outcomes.

    Learning Objectives

    At the conclusion of this activity, the participant will be able to:

    • Describe the clinical, endoscopic, and histopathologic features of eosinophilic esophagitis
    • Summarize resuscitation, initial management, transfusion recommendations, and timing of endoscopy for peptic ulcer bleeding
    • Explain the differential diagnosis, evaluation, and management of diarrhea.
    • Discuss inflammatory bowel disease diagnostic tools and work-up for appropriate patients
    • Identify the risk factors that warrant screening for hepatitis C
    • Recognize clinical trends in drug-induced liver injury
    • List the possible pathogenic mechanisms of pancreatitis and how that informs drug targets and treatments
    • Differentiate between acute calculous cholecystitis and acute acalculous cholecystitis
    • List the core principles of obesity treatment
    • Name the gastrointestinal manifestations of COVID-19 infection

    Intended Audience


    This educational activity was designed for gastroenterologists, hepatologists, internists, fellows in gastroenterology, and internal medicine residents interested in gastroenterology and hepatology.

    TOPICS / SPEAKERS

    Esophagus

    • Gastroesophageal Reflux Disease (GERD) and Barrett’s Esophagus – Stuart Jon Spechler, MD
    • Esophageal Motility and Structural Disorders – Dustin A. Carlson, MD
    • Update in Eosinophilic Esophagitis and Eosinophilic Gastrointestinal Diseases – Evan S. Dellon, MD, MPH
    • Esophageal Cancer – Anil K. Rustgi, MD

    Stomach and Small Intestine

    • Pathophysiology of Peptic Ulcer Disease – Helen M. Shields, MD
    • Peptic Ulcer Hemorrhage – Diagnosis and Management – Dennis M. Jensen, MD
    • Motility Disorders – Gastroparesis, Functional Dyspepsia, Ileus – Braden Kuo, MD, MSc
    • Malabsorption and Nutrition – Henry J. Binder, MD
    • Viral/Bacterial Gastroenteritis – Jason B. Harris, MD, MPH
    • Constipation and Diarrhea – Lawrence R. Schiller, MD
    • Celiac Disease and Gluten Sensitivity – Peter H. R. Green, MD

    Colon

    • Diagnosis and Management of Clostridioides difficile Infections – Jessica R. Allegretti, MD, MPH
    • Inflammatory Bowel Disease – Anita Afzali, MD, MPH, MHCM
    • Irritable Bowel Syndrome – Walter W. Chan, MD, MPH, FACG, AGAF
    • Ischemic Bowel Disorders – A Case Based Approach – Paul Feuerstadt, MD
    • Colorectal Cancer Screening Strategies – Shilpa Grover, MD, MPH
    • An Update on Colorectal and Anal Cancers – Robert J. Mayer, MD
    • Hereditary Gastrointestinal Polyposis/Cancer Syndromes – John M. Carethers, MD, MACP

    Liver – Hepatitis

    • Viral Hepatitis Overview – Raymond T. Chung, MD
    • Hepatitis B – Norah Terrault, MD, MPH
    • Hepatitis C – Ira M. Jacobson, MD
    • HIV – Viral Hepatitis Co-Infection – Kenneth E. Sherman, MD, PhD

    Liver – General

    • Drug-Induced Liver Injury – Idiosyncratic (iDILI) and Acetaminophen – William M. Lee, MD, FACP, FAASLD, AGAF
    • Nonalcoholic Fatty Liver Disease – Stephen A. Harrison, MD
    • Alcohol-Associated Hepatitis – Jay Luther, MD
    • Autoimmune Liver Disorders – John M. Vierling, MD, FACP, FAASLD, AGAF
    • Genetic Liver Disorders – Kris V. Kowdley, MD, FACP
    • Hepatic Decompensation – Andrea Ewing Reid, MD, MPH
    • Hepatocellular Carcinoma – Augusto Villanueva, MD
    • Liver Transplantation – Thomas D. Schiano, MD
    • Liver Fibrosis – Don C. Rockey, MD

    Pancreas

    • Acute Pancreatitis – Yasmin Genevieve Hernandez-Barco, MD
    • Recurrent-Chronic Pancreatitis – Evaluation and New Therapies – Steven D. Freedman, MD, PhD
    • Update in Pancreatic Cancer – William R. Brugge, MD

    Biliary Tract

    • Gallstones, Gallbladder, and Biliary Tract Disease – Muthoka L. Mutinga, MD
    • Cholangiocarcinoma – Sumera I. Ilyas, MD

    Special Topics

    • Gut Microbiome – Aonghus Lavelle, MD, PhD
    • Approach to Gastrointestinal Hemorrhage – John R. Saltzman, MD
    • A New Era in Obesity Treatment – Lee M. Kaplan, MD, PhD
    • COVID-19 – Gastrointestinal Manifestations – Thomas R. McCarty, MD
    • Gastrointestinal and Hepatic Toxicities of Checkpoint Blockade – Michael Dougan, MD
    • Acute Gastrointestinal Toxicity of Novel Anti-Cancer Therapies – Shilpa Grover, MD, MPH

     

    Date of Original Release: August 31, 2023